Łoniewska Beata, Adamek Karolina, Węgrzyn Dagmara, Kaczmarczyk Mariusz, Skonieczna-Żydecka Karolina, Clark Jeremy, Adler Grażyna, Tousty Joanna, Uzar Izabela, Tousty Piotr, Łoniewski Igor
Department of Neonatal Diseases, Pomeranian Medical University, Szczecin 70-111, Poland.
Department of Clinical and Molecular Biochemistry, Pomeranian Medical University, Szczecin 70-111, Poland.
J Clin Med. 2020 Mar 12;9(3):777. doi: 10.3390/jcm9030777.
Factors affecting the intestinal-barrier permeability of newborns, such as body mass index (BMI), nutrition and antibiotics, are assumed to affect intestinal-barrier permeability in the first two years of life. This study assessed 100 healthy, full-term newborns to 24 months old. Faecal zonulin/calprotectin concentrations were measured at 1, 6, 12, 24 months as gut-permeability markers. Zonulin concentrations increased between 1 and 12 months (medians: 114.41, 223.7 ng/mL; respectively), whereas calprotectin concentrations decreased between one and six months (medians: 149. 29, 109.28 µg/mL); both then stabilized (24 months: 256.9 ng/mL zonulin; 59.5 µg/mL calprotectin). In individual children, high levels at one month gave high levels at older ages (correlations: calprotectin: between 1 and 6 or 12 months: correlation coefficient ( = 0.33, statistical significance = 0.0095; = 0.28, = 0.032; zonulin: between 1 and 24 months: = 0.32; = 0.022, respectively). Parameters which gave marker increases: antibiotics during pregnancy (calprotectin; six months: by 80%, p = 0.038; 12 months: by 48%, = 0.028); vaginal birth (calprotectin: 6 months: by 140%, = 0.005); and > 5.7 pregnancy-BMI increase (zonulin: 12 months: by 74%, = 0.049). Conclusions: "Closure of the intestines" is spread over time and begins between the sixth and twelfth month of life. Antibiotic therapy, BMI increase > 5.7 during pregnancy and vaginal birth are associated with increased intestinal permeability during the first two years of life. Stool zonulin and calprotectin concentrations were much higher compared with previous measurements at older ages; clinical interpretation and validation are needed (no health associations found).
诸如体重指数(BMI)、营养和抗生素等影响新生儿肠道屏障通透性的因素,被认为会在生命的头两年影响肠道屏障通透性。本研究评估了100名健康的足月新生儿至24个月大的婴儿。在1、6、12、24个月时测量粪便中连蛋白/钙卫蛋白浓度作为肠道通透性标志物。连蛋白浓度在1至12个月之间升高(中位数分别为:114.41、223.7 ng/mL),而钙卫蛋白浓度在1至6个月之间降低(中位数分别为:149.29、109.28 µg/mL);随后两者均趋于稳定(24个月时:连蛋白为256.9 ng/mL;钙卫蛋白为59.5 µg/mL)。在个体儿童中,1个月时的高水平在较大年龄时也为高水平(相关性:钙卫蛋白:在1至6个月或12个月之间:相关系数(r)= 0.33,统计学显著性(p)= 0.0095;r = 0.28,p = 0.032;连蛋白:在1至24个月之间:r = 0.32;p = 0.022)。导致标志物升高的因素有:孕期使用抗生素(钙卫蛋白;6个月时:升高80%,p = 0.038;12个月时:升高48%,p = 0.028);阴道分娩(钙卫蛋白:6个月时:升高140%,p = 0.005);以及孕期BMI增加> 5.7(连蛋白:12个月时:升高74%,p = 0.049)。结论:“肠道闭合”随时间推移发生,始于生命的第六至十二个月。抗生素治疗、孕期BMI增加> 5.7以及阴道分娩与生命头两年肠道通透性增加有关。与之前对较大年龄儿童的测量相比,粪便连蛋白和钙卫蛋白浓度要高得多;需要进行临床解读和验证(未发现与健康的关联)。